Georgios F Samelis

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. ncbi Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients
    Georgios F Samelis
    Oncology Department, University of Athens, Medical School, Greece
    Hepatogastroenterology 58:1776-81. 2011

Detail Information

Publications1

  1. ncbi Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients
    Georgios F Samelis
    Oncology Department, University of Athens, Medical School, Greece
    Hepatogastroenterology 58:1776-81. 2011
    ..The aim of the present study was to record the efficacy and safety of gemcitabine-erlotinib plus docetaxel combination therapy in patients with advanced and/or metastatic pancreatic cancer...